F2 and incontinentia pigmenti: Higher anti-PT IgG concentrations (P < .001) and epitope-specific inhibition targeting 1B7 (P = .049) and 11E6 (P = .02) were noted at age 6 months in control group infants, suggesting epitope-specific blunting in the IP group.